Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication

NCT00152581 is registered in ClinicalTrials.gov with University College London Hospitals as lead sponsor.

NCT NCT00152581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00152581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication
Lead sponsor
University College London Hospitals
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2002
Completion date
Not reported
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, hcv genotype 1